Bristol Myers Squibb has released its financial results for the second quarter of 2025. The announcement was made from Princeton, New Jersey, and d...
Curis, Inc., a biotechnology company, is set to report its second quarter 2025 financial and operating results on August 5, 2025. The company focus...
Alkermes plc reported second-quarter earnings from continuing operations of 52 cents per share, exceeding the Zacks Consensus Estimate of 41 cents....
Alkermes plc has reported second-quarter earnings of 52 cents per share, surpassing the Zacks Consensus Estimate of 41 cents. Total revenues reache...
(Reuters) -AstraZeneca beat second-quarter earnings expectations on Tuesday, helped by strong sales of key cancer, heart and kidney disease drugs, ...
InfuSystem Holdings, Inc. is set to release its second quarter 2025 financial results on August 5, 2025, before the market opens. The company will ...
UnitedHealth Group reported disappointing second-quarter earnings, with adjusted earnings of $4.08 per share on $111.6 billion in revenue, falling ...
Merck & Co., Inc., headquartered in Rahway, New Jersey, reported its financial results for the second quarter of 2025. The company announced total ...
Bristol Myers Squibb (BMS) has partnered with Bain Capital to launch a new biotech company focused on developing therapies for autoimmune disorders...
Bristol Myers Squibb (BMS) has announced an expansion of its cost-cutting measures, adding $2 billion in savings through 2027. This move is part of...